Following the Federal Reserve's unanimous decision to raise interest rates on September 16, US Treasury yields surged across the curve. The Fed's strong stance on combating inflation has led to higher yields, influenced not only by terminal rates and oil prices but also by the interaction between fiscal and monetary policies. This dynamic may worsen the primary deficit and increase the debt ratio, despite rising risk premiums. The analyst suggests that while short-term yield reversals are unlikely, entering the market at yields above 5.30% could be a lucrative strategy given the current equity yield environment.
The bond market's view on Fed target rates and inflation is provided here with Pluang's market data for context. As of Oct 08, 2026 18:43 WIB, 40 out of 150 US stocks on Pluang rose while 107 fell. Notable movers include Carnival Corp at USD 25.58 with a 2.18% decline, Exxon Mobil Corporation at USD 167.63 gaining 2.18%, and Freeport-McMoRan Inc at USD 70.32 down 2.15%.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
